{"id":9549,"date":"2024-11-08T18:32:04","date_gmt":"2024-11-08T10:32:04","guid":{"rendered":"https:\/\/www.excelsiormedical.com.tw\/?p=9549"},"modified":"2024-11-12T09:29:00","modified_gmt":"2024-11-12T01:29:00","slug":"the-board-of-directors-approved-q3-2024-consolidated-financial-statements","status":"publish","type":"post","link":"https:\/\/www.excelsiormedical.com.tw\/en\/investors\/the-board-of-directors-approved-q3-2024-consolidated-financial-statements\/","title":{"rendered":"The Board of Directors approved Q3 2024 consolidated financial statements."},"content":{"rendered":"

 <\/p>\n\n\n\n\n\n\n
SEQ_NO<\/td>\n\u00a01<\/td>\nDate of announcement<\/td>\n2024\/11\/08<\/td>\nTime of announcement<\/td>\n18:32:37<\/td>\n<\/tr>\n
Subject<\/td>\n\n
The Board of Directors approved Q3 2024 consolidated financial statements.<\/pre>\n<\/td>\n<\/tr>\n
Date of events<\/td>\n2024\/11\/08<\/td>\nTo which item it meets<\/td>\nparagraph 31<\/td>\n<\/tr>\n
Statement<\/td>\n\n
1.Date of submission to the board of directors or approval\r\n  by the board of directors:2024\/11\/08\r\n2.Date of approval by the audit committee:2024\/11\/08\r\n3.Start and end dates of financial reports or annual \r\n  self-assessed financial information of the reporting \r\n  period (XXXX\/XX\/XX~XXXX\/XX\/XX):2024\/01\/01~2024\/09\/30\r\n4.Operating revenue accumulated from 1\/1 to end of the \r\n  period(thousand NTD):6,260,706\r\n5.Gross profit (loss) from operations accumulated from\r\n  1\/1 to end of the period (thousand NTD):1,278,676\r\n6.Net operating income (loss) accumulated from 1\/1 to\r\n  end of the period (thousand NTD):527,164\r\n7.Profit (loss) before tax accumulated from 1\/1 to end\r\n  of the period (thousand NTD):859,581\r\n8.Profit (loss) accumulated from 1\/1 to end of the period\r\n (thousand NTD):713,414\r\n9.Profit (loss) during the period attributable to owners\r\n  of parent accumulated from 1\/1 to end of the period\r\n  (thousand NTD):579,105\r\n10.Basic earnings (loss) per share accumulated from 1\/1 \r\n   to end of the period (NTD):3.54\r\n11.Total assets end of the period (thousand NTD):21,943,843\r\n12.Total liabilities end of the period (thousand NTD):\r\n   10,878,400\r\n13.Equity attributable to owners of parent end of the\r\n   period (thousand NTD):8,775,837\r\n14.Any other matters that need to be specified:None.\r\n<\/pre>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n","protected":false},"excerpt":{"rendered":"
  SEQ_NO \u00a01 Date of announcement 2024\/11\/08 Time of announcement 18:32:37 Subject The Board of Directors approved Q3 2024 consolidated financial statements. Date of events 2024\/11\/08 To which item it meets paragraph 31 Statement 1.Date of submission to the board of directors or approval by the board of directors:2024\/11\/08 2.Date of approval by the audit …<\/p>\n
  The Board of Directors approved Q3 2024 consolidated financial statements.<\/span> Read More »<\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"site-sidebar-layout":"default","site-content-layout":"default","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"default","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","footnotes":"","_links_to":"","_links_to_target":""},"categories":[72,102],"tags":[],"class_list":["post-9549","post","type-post","status-publish","format-standard","hentry","category-investors","category-material-information"],"_links":{"self":[{"href":"https:\/\/www.excelsiormedical.com.tw\/en\/wp-json\/wp\/v2\/posts\/9549","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.excelsiormedical.com.tw\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.excelsiormedical.com.tw\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.excelsiormedical.com.tw\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.excelsiormedical.com.tw\/en\/wp-json\/wp\/v2\/comments?post=9549"}],"version-history":[{"count":3,"href":"https:\/\/www.excelsiormedical.com.tw\/en\/wp-json\/wp\/v2\/posts\/9549\/revisions"}],"predecessor-version":[{"id":9552,"href":"https:\/\/www.excelsiormedical.com.tw\/en\/wp-json\/wp\/v2\/posts\/9549\/revisions\/9552"}],"wp:attachment":[{"href":"https:\/\/www.excelsiormedical.com.tw\/en\/wp-json\/wp\/v2\/media?parent=9549"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.excelsiormedical.com.tw\/en\/wp-json\/wp\/v2\/categories?post=9549"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.excelsiormedical.com.tw\/en\/wp-json\/wp\/v2\/tags?post=9549"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}